Algo version: 0.98b
Cell Source Inc is listed at the PNK Exchange
Cell Source Inc [CLCS]
PNK Sector: Healthcare Industry:Biotechnology

Is Cell Source Inc stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Cell Source Inc 10 years ago, but if you had invested on Monday 25th of November 2019 when the price was $0.561, you would have made a profit of $0.0022 per share or 0.39%

No, the average daily trading liquidity for Cell Source Inc is $18 982 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Cell Source Inc has much of the business financed by loans. This puts the company at high risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Cell Source Inc to be high [0.9 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.